Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS+HIPEC)

Journal of Surgical Oncology

Volumn 106, Issue 4, 2012, Pages 376-380

  Duckworth, Katharine E ^a   McQuellon, Richard P ^a   Russell, Gregory B ^a   Cashwell, Craig S ^b   Shen, Perry ^a   Stewart IV, John H ^a   Levine, Edward A ^a  

^a WAKE FOREST BAPTIST HEALTH   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

health related quality of life; long term survivorship; peritoneal carcinomatosis

Indexed keywords

ANTINEOPLASTIC AGENT;

APPENDIX CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COLON CANCER; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MAJOR CLINICAL STUDY; MALE; MESOTHELIOMA; OUTCOME ASSESSMENT; OVARY CANCER; PITTSBURGH SLEEP QUALITY INDEX; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER; SLEEP QUALITY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; QUALITY OF LIFE; SLEEP; TREATMENT OUTCOME;

EID: 84865111801     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23089     Document Type: Article

References (22)

1. Levine EA, Stewart JH, Russell GB, et al.: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: Experience with 501 procedures. J Am Coll Surg 2007; 204: 943-953. (Pubitemid 46661217)
2. Stewart JH, Shen P, Levine EA:, Intraperitoneal hyperthermic chemotherapy: An evolving paradigm for the treatment of peritoneal surface malignancies. Expert Rev Anticancer Ther 2008; 8: 1809-1818.
3. McQuellon RP, Loggie BW, Lehman AB, et al.: Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003; 10: 155-162. (Pubitemid 40485936)
4. McQuellon RP, Danhauer SC, Russell GB, et al.: Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2007; 14: 1105-1113.
5. McQuellon RP, Russell GB, Shen P, et al.: Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. Ann Surg Oncol 2008; 15: 125-133.
6. McQuellon R, Duckworth KE:, Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Curr Probl Cancer 2009; 33: 203-218.
7. Horning SJ:, Follow-up of adult cancer survivors: New paradigms for survivorship care planning. Hematol Oncol Clin North Am 2008; 22: 201-210. (Pubitemid 351452098)
8. Savard J, Morin CM:, Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol 2001; 19: 895-908. (Pubitemid 32119105)
9. Colten HR, Altevogt BM:, Sleep disorders and sleep deprivation: An unmet public health problem. Institute of Medicine (US) committee on sleep medicine and research. Washington, DC: National Academies Press (US); 2006.
10. Ware JE, Jr., Sherbourne CD:, The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
11. Ware JE, Jr., Kosinski M, Bjorner JB:, Users manual for the SF-36v2 health survey. Lincoln, RI: Quality Metric Incorporated; 2007.
12. Ware JE, Jr., Snow KK, Kosinski M:, SF-36 health survey. Manual and interpretation guide. Boston: Nimrod Press; 1993.
13. Cella DF, Tulsky DS, Gray G, et al.: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 1993; 11: 570-579. (Pubitemid 23071057)
14. Buysse DJ, Reynolds CF III, Monk TH, et al.: The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213. (Pubitemid 19144991)
15. Tedeschi RG, Calhoun LG:, The Posttraumatic Growth Inventory: Measuring the positive legacy of trauma. J Trauma Stress 1996; 9: 455-471. (Pubitemid 126710047)
16. Stanton AL, Bower JE, Low CC:, Posttraumatic growth after cancer. In:, Calhoun LG, Tedeschi RG, editors. Handbook of postraumatic growth: Research and practice. London: Lawrence Erlbaum; 2006. pp. 138-175.
17. Sprangers MA, Schwartz CE:, The challenge of response shift for quality-of-life-based clinical oncology research. Ann Oncol 1999; 10: 747-749. (Pubitemid 29367988)
18. Sprangers MA, Moinpour CM, Moynihan TJ:, Assessing meaningful change in quality of life over time: A users' guide for clinicians. Mayo Clin Proc 2002; 77: 561-571. (Pubitemid 34587346)
19. Brucker PS, Yost K, Cashy J, et al.: General population and cancer patient norms for the Functional Assessment of Cancer Therapy-General (FACT-G). Eval Health Prof 2005; 28: 192-211. (Pubitemid 40628907)
20. Strine TW, Chapman DP:, Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med 2005; 6: 23-27.
21. Tuttle TM, Zhang Y, Greeno E, et al.: Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2006; 13: 1627-1632. (Pubitemid 44951472)
22. McQuellon RP, Loggie BW, Fleming RA, et al.: Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001; 27: 65-73. (Pubitemid 32229697)